Comparative analysis of human and kangaroo leishmania: defining human pathogenicity genes

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Leishmaniasis is a global infectious disease affecting millions and killing thousands each year. This project will utilise the recent discovery in Australia of a related pathogen to identify novel parasite genes and pathways involved in virulence in humans. The latest techniques in comparative genomics and molecular biology will identify the genes that cause human disease . Appropriate genes will then be used to develope a novel vaccine using the Australian parasite.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $539,334.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Immunogenetics (incl. Genetic Immunology)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Comparative genomics | Infectious disease | Molecular basis of disease | Molecular typing | Parasite infection | Vaccine development | gene expression | molecular biology